• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Significant influence of accompanying chronic hepatitis status on recurrence of hepatocellular carcinoma after hepatectomy. Result of multivariate analysis.伴发慢性肝炎状态对肝切除术后肝细胞癌复发的显著影响。多因素分析结果。
Ann Surg. 1996 Nov;224(5):591-5. doi: 10.1097/00000658-199611000-00001.
2
Influence of associated viral hepatitis status on recurrence of hepatocellular carcinoma after hepatectomy.合并病毒性肝炎状态对肝癌肝切除术后复发的影响。
World J Surg. 1996 Oct;20(8):1082-6. doi: 10.1007/s002689900164.
3
Influence of accompanying chronic hepatitis status on recurrence of hepatocellular carcinoma after hepatectomy.慢性肝炎伴随状态对肝切除术后肝细胞癌复发的影响。
Ann Surg. 1996 Nov;224(5):596-7. doi: 10.1097/00000658-199611000-00002.
4
Liver fibrosis increases the risk of intrahepatic recurrence after hepatectomy for hepatocellular carcinoma.肝纤维化会增加肝细胞癌肝切除术后肝内复发的风险。
Br J Surg. 2002 Jan;89(1):57-62. doi: 10.1046/j.0007-1323.2001.01969.x.
5
Risk of recurrence in a long-term follow-up after surgery in 417 patients with hepatitis B- or hepatitis C-related hepatocellular carcinoma.417例乙型或丙型肝炎相关肝细胞癌患者术后长期随访的复发风险
Ann Surg. 2006 Nov;244(5):771-80. doi: 10.1097/01.sla.0000225126.56483.b3.
6
Forns index predicts recurrence and death in patients with hepatitis B-related hepatocellular carcinoma after curative resection.福尔恩指数可预测乙肝相关肝细胞癌患者根治性切除术后的复发和死亡情况。
Liver Int. 2015 Aug;35(8):1992-2000. doi: 10.1111/liv.12776. Epub 2015 Jan 22.
7
Prognostic roles of preoperative α-fetoprotein and des-γ-carboxy prothrombin in hepatocellular carcinoma patients.术前甲胎蛋白和脱γ-羧基凝血酶原在肝细胞癌患者中的预后作用
World J Gastroenterol. 2015 Apr 28;21(16):4933-45. doi: 10.3748/wjg.v21.i16.4933.
8
The Impact of the Hepatitis B Core Antibody Status on Recurrence in Patients with Non-B Non-C Hepatocellular Carcinoma after Curative Surgery.乙肝核心抗体状态对非B非C型肝细胞癌患者根治性手术后复发的影响
Dig Surg. 2018;35(3):243-251. doi: 10.1159/000479340. Epub 2017 Aug 16.
9
Effect of Background Liver Cirrhosis on Outcomes of Hepatectomy for Hepatocellular Carcinoma.背景性肝硬化对肝细胞癌肝切除术结局的影响。
JAMA Surg. 2017 Mar 15;152(3):e165059. doi: 10.1001/jamasurg.2016.5059.
10
Outcomes after curative hepatectomy in patients with non-B non-C hepatocellular carcinoma and hepatitis B virus hepatocellular carcinoma from non-cirrhotic liver.非肝硬化肝脏中非 B 非 C 型肝细胞癌和乙型肝炎病毒相关性肝细胞癌患者根治性肝切除术后的结局。
J Surg Oncol. 2014 Dec;110(8):976-81. doi: 10.1002/jso.23772. Epub 2014 Aug 29.

引用本文的文献

1
CT-Based Radiomics Nomogram Improves Risk Stratification and Prediction of Early Recurrence in Hepatocellular Carcinoma After Partial Hepatectomy.基于CT的影像组学列线图改善了肝癌肝部分切除术后早期复发的风险分层和预测。
Front Oncol. 2022 Jul 7;12:896002. doi: 10.3389/fonc.2022.896002. eCollection 2022.
2
Improvement of Image Quality Using Hybrid Iterative Reconstruction with Noise Power Spectrum Model in Computed Tomography During Hepatic Arteriography.在肝脏血管造影计算机断层扫描中使用带噪声功率谱模型的混合迭代重建提高图像质量
J Belg Soc Radiol. 2021 Sep 14;105(1):43. doi: 10.5334/jbsr.2444. eCollection 2021.
3
Narrow-Margin Hepatectomy Resulted in Higher Recurrence and Lower Overall Survival for R0 Resection Hepatocellular Carcinoma.窄切缘肝切除术导致R0切除的肝细胞癌复发率更高、总生存率更低。
Front Oncol. 2021 Jan 21;10:610636. doi: 10.3389/fonc.2020.610636. eCollection 2020.
4
Development and Assessment of Novel Predictive Nomograms Based on APRI for Hepatitis B Virus-associated Small Solitary Hepatocellular Carcinoma with Stereotactic Body Radiotherapy.基于APRI的新型预测列线图在乙型肝炎病毒相关性小孤立性肝细胞癌立体定向体部放疗中的开发与评估
J Cancer. 2020 Sep 23;11(22):6642-6652. doi: 10.7150/jca.47291. eCollection 2020.
5
Liver fibrosis is a major risk factor for liver regeneration: A comparison between healthy and fibrotic liver.肝纤维化是肝脏再生的主要危险因素:健康肝脏与纤维化肝脏的比较。
Medicine (Baltimore). 2020 May 29;99(22):e20003. doi: 10.1097/MD.0000000000020003.
6
Adjuvant pegylated interferon therapy improves the survival outcomes in patients with hepatitis-related hepatocellular carcinoma after curative treatment: A meta-analysis.辅助聚乙二醇化干扰素治疗可改善根治性治疗后肝炎相关肝细胞癌患者的生存结局:一项荟萃分析。
Medicine (Baltimore). 2018 Jul;97(28):e11295. doi: 10.1097/MD.0000000000011295.
7
The effect of antiviral therapy on patients with hepatitis B virus-related hepatocellular carcinoma after curative resection: a systematic review and meta-analysis.抗病毒治疗对乙型肝炎病毒相关肝细胞癌患者根治性切除术后的影响:一项系统评价和荟萃分析。
Onco Targets Ther. 2017 Nov 10;10:5363-5375. doi: 10.2147/OTT.S150281. eCollection 2017.
8
Prevention of cancer recurrence after treatment for hepatitis C virus-related hepatocellular carcinoma by interferon therapy.干扰素治疗对丙型肝炎病毒相关肝细胞癌治疗后癌症复发的预防作用。
Clin J Gastroenterol. 2009 Apr;2(2):65-70. doi: 10.1007/s12328-009-0072-1. Epub 2009 Apr 8.
9
Nucleos(t)ide analogue therapy for HBV-related HCC after hepatic resection: clinical benefits and unanswered questions.肝切除术后核苷(酸)类似物治疗HBV相关肝癌:临床益处与未解决的问题
Tumour Biol. 2014 Dec;35(12):12779-84. doi: 10.1007/s13277-014-2881-1. Epub 2014 Nov 28.
10
Liver stiffness value-based risk estimation of late recurrence after curative resection of hepatocellular carcinoma: development and validation of a predictive model.基于肝脏硬度值的肝细胞癌根治性切除术后晚期复发风险评估:预测模型的建立与验证
PLoS One. 2014 Jun 9;9(6):e99167. doi: 10.1371/journal.pone.0099167. eCollection 2014.

本文引用的文献

1
Is high AgNOR quantity in hepatocytes associated with increased risk of hepatocellular carcinoma in chronic liver disease?慢性肝病中肝细胞内高银染核仁组织区数量是否与肝细胞癌风险增加有关?
J Clin Pathol. 1993 Aug;46(8):727-9. doi: 10.1136/jcp.46.8.727.
2
Recurrence of hepatocellular carcinoma in the liver remnant after hepatic resection.肝切除术后肝残余组织中肝细胞癌的复发
Am J Surg. 1993 Sep;166(3):270-3. doi: 10.1016/s0002-9610(05)80972-9.
3
Liver resection for hepatocellular carcinoma. Results of 229 consecutive patients during 11 years.肝细胞癌的肝切除术。11年间229例连续患者的结果。
Ann Surg. 1993 Apr;217(4):375-84. doi: 10.1097/00000658-199304000-00009.
4
Classification of chronic hepatitis: diagnosis, grading and staging.慢性肝炎的分类:诊断、分级和分期。
Hepatology. 1994 Jun;19(6):1513-20.
5
Identification and screening of 416 patients with chronic hepatitis at high risk to develop hepatocellular cancer.对416例有发展为肝细胞癌高风险的慢性肝炎患者进行识别与筛查。
Ann Surg. 1995 Sep;222(3):375-80; discussion 380-3. doi: 10.1097/00000658-199509000-00014.
6
Significance of hepatocellular proliferation in the development of hepatocellular carcinoma from anti-hepatitis C virus-positive cirrhotic patients.抗丙型肝炎病毒阳性肝硬化患者肝细胞增殖在肝细胞癌发生中的意义。
Cancer. 1994 Feb 15;73(4):1149-54. doi: 10.1002/1097-0142(19940215)73:4<1149::aid-cncr2820730405>3.0.co;2-9.
7
Limited hepatic resection effective for selected cirrhotic patients with primary liver cancer.有限肝切除术对特定的原发性肝癌肝硬化患者有效。
Ann Surg. 1984 Jan;199(1):51-6. doi: 10.1097/00000658-198401000-00009.
8
Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan.肝细胞癌与乙型肝炎病毒。对台湾22707名男性的前瞻性研究。
Lancet. 1981 Nov 21;2(8256):1129-33. doi: 10.1016/s0140-6736(81)90585-7.
9
Liver carcinomas induced in rats by single administration of dimethylnitrosamine after partial hepatectomy.部分肝切除术后单次给予二甲基亚硝胺诱导大鼠发生肝癌。
J Natl Cancer Inst. 1971 Oct;47(4):899-907.
10
A classification of chronic hepatitis.慢性肝炎的一种分类
Lancet. 1968 Sep 14;2(7568):626-8. doi: 10.1016/s0140-6736(68)90710-1.

伴发慢性肝炎状态对肝切除术后肝细胞癌复发的显著影响。多因素分析结果。

Significant influence of accompanying chronic hepatitis status on recurrence of hepatocellular carcinoma after hepatectomy. Result of multivariate analysis.

作者信息

Ko S, Nakajima Y, Kanehiro H, Hisanaga M, Aomatsu Y, Kin T, Yagura K, Ohyama T, Nishio K, Ohashi K, Sho M, Yamada T, Nakano H

机构信息

First Department of Surgery, Nara Medical University, Kashihara, Japan.

出版信息

Ann Surg. 1996 Nov;224(5):591-5. doi: 10.1097/00000658-199611000-00001.

DOI:10.1097/00000658-199611000-00001
PMID:8916872
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1235434/
Abstract

OBJECTIVE

The aim of this study was to evaluate the correlation between the histologic status of accompanying chronic hepatitis and the recurrence rate of hepatocellular carcinoma (HCC) after hepatectomy by multivariate analysis.

SUMMARY BACKGROUND DATA

Recent studies have suggested that a considerable number of intrahepatic recurrence of HCC after hepatectomy might be the results of metachronous multicentric hepatocarcinogenesis. The authors hypothesized that the incidence of recurrence due to metachronous multicentric hepatocarcinogenesis would depend on the histologic status of accompanying chronic viral liver disease, which is a main promoter of HCC.

METHODS

One hundred ten patients with HCC who underwent curative resection were studied. Histologic status of accompanying chronic hepatitis was classified into the three categories: 1) normal liver or chronic persistent hepatitis (CPH, n = 13), 2) chronic aggressive hepatitis (CAH, n = 50), and 3) liver cirrhosis (LC, n = 47).

RESULTS

The Cox multivariate proportional hazard model showed that the accompanying chronic viral hepatitis status (p = 0.0133), extent of hepatectomy (p = 0.0078), and number of tumors (p = 0.0475) were significantly predictive variables for recurrence-free survival. By the log-rank test, recurrence-free survival rate in patients with CPH was significantly higher than those in patients with CAH (p = 0.0005) and LC (p = 0.0075). Patients with CAH had the lowest recurrence-free survival rate (vs. LC, p = 0.028).

CONCLUSIONS

The results of this study indicated the significant influence of histologic activity of hepatitis on recurrence of HCC. This might support the concept of significant contribution of multicentric hepatocarcinogenesis to recurrence of HCC after hepatectomy.

摘要

目的

本研究旨在通过多因素分析评估伴发慢性肝炎的组织学状态与肝细胞癌(HCC)肝切除术后复发率之间的相关性。

总结背景数据

近期研究表明,肝切除术后相当数量的HCC肝内复发可能是异时多中心肝癌发生的结果。作者推测,异时多中心肝癌发生导致的复发发生率将取决于伴发慢性病毒性肝病的组织学状态,而慢性病毒性肝病是HCC的主要促发因素。

方法

对110例行根治性切除的HCC患者进行研究。将伴发慢性肝炎的组织学状态分为三类:1)正常肝脏或慢性持续性肝炎(CPH,n = 13),2)慢性活动性肝炎(CAH,n = 50),3)肝硬化(LC,n = 47)。

结果

Cox多因素比例风险模型显示,伴发慢性病毒性肝炎状态(p = 0.0133)、肝切除范围(p = 0.0078)和肿瘤数量(p = 0.0475)是无复发生存的显著预测变量。通过对数秩检验,CPH患者的无复发生存率显著高于CAH患者(p = 0.0005)和LC患者(p = 0.0075)。CAH患者的无复发生存率最低(与LC相比,p = 0.028)。

结论

本研究结果表明肝炎的组织学活性对HCC复发有显著影响。这可能支持多中心肝癌发生对肝切除术后HCC复发有重大贡献的概念。